Zhu H-H, Hu J, Lo-Coco F, Jin J. The simpler, the better: oral arsenic for acute promyelocytic leukemia. Blood. 2019;134(7):597-605.

There are errors in Table 1 on pages 600 to 602. Many entries that should be in a single table cell are divided among multiple cells. Throughout the table, the unit “ms” should read “m²”. In the information for reference Iland 2015¹³ (page 601), in the “Induction” column, in “ATO 0.15 mg/kg/days 9-36 + ATRA 45 mg/ms/days 1-36 + IDA 6-12 mg/ms/days 2, 4, 6, 8,” “6-12” should read “6, 9, or 12”; in the “Consolidation” column, in “ATRA 45 mg/ms/d days 1-7,15-21 and 29-35 + ATO 0.15 mg/kg/d 5 d per week for 5 wk for 2rd cycle,” “2rd” should read “2nd”; and in the “Maintenance” column, “6-MP 50-90 mg/m²/wk days 15-90” should appear once rather than twice. In the information for reference Yang 2018⁴⁸ (page 602), the reference number should be 47 instead of 48, and in the “Induction” column, “ATO 0.16 mg/kg/d + ATRA 25 mg/ms/d +” should read “ATO 0.16 mg/kg/d + ATRA 25 mg/m²/d + mitoxantrone.” In the footnote, the abbreviation PO should be defined as “by mouth,” not “postoperatively.” The corrected table follows.